Colonic Neoplasms Clinical Trial
Official title:
Early Closure of the Derivative Ileostomy Versus Conventional Closure in Postoperative Patients With Low Anterior Resection for Rectal Cancer
Colorectal cancer worldwide is the third most common in men and the second in female, although mortality is not as high as its incidence, there is less survival in developing countries. According to data from the World Health Organization, in 2012, there were an estimated 1.4 million cases and 693,900 deaths from this disease. Patients with rectal cancer are frequently taken to resection surgery as a curative management of their malignant pathology, according to the type of resection or reconstruction. In a high number of cases, they are management with colorectal anastomosis with a derivative ileostomy in the same procedure. The closure of this ileostomy is usually done after two to three months of the procedure, however in our environment it could take up to six or twelve months, during which time the patient is exposed to social difficulties, management problems and complications, derived from it. The early closure (7-12 days of its creation) of an ileostomy, despite the little evidence, seems to be a safe, feasible procedure that would save the patient having to live temporarily with an ileostomy.
General purpose:
To compare the frequency of perioperative complications and quality of life between early
closure of the derivative ileostomy versus conventional closure in postoperative patients
with low anterior resection for rectal cancer.
Materials and methods:
Controlled clinical trial, randomized, to be carried out at the National Cancer Institute of
Colombia E.S.E. Eligible candidates for the study will be patients older than 18 years who
have undergone a previous resection of the rectum plus a derivative ileostomy for colorectal
cancer. All patients eligible for inclusion will undergo computed axial tomography with
rectal contrast medium on postoperative day 5. Those who meet the inclusion criteria and do
not present any of the exclusion criteria will enter the study, prior willingness to
participate by part of the patient and obtaining verbal and written informed consent. Through
computer-generated randomization, patients will undergo early closure (between 7 and 12 days
after the ileostomy) versus conventional closure (after 90 days or more time from the
creation of the ileostomy). A sample size of 81 patients was calculated for each arm. The
follow-up will be done in both groups at 3, 6, 9 and 12 months after the creation of the
ileostomy, including complications using the Clavien-Dindo classification and quality of life
using the FACIT-C format. The statistical analysis will be done by protocol and intention to
treat. The perioperative complications associated with the closure of the ileostomy, the
complications associated with the presence of ileostomy, hospital stay, and quality of life
will be analyzed.
Expected impact:
The investigators hope to find that the early closure of ileostomy in patients during the
immediate postoperative period of previous resection due to rectal cancer is safe in terms of
morbidity and mortality, feasible and with benefits in quality of life during the immediate
postoperative period compared with patients to whom they are closed late (after 3 months).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05809999 -
IBD Neoplasia Surveillance RCT
|
N/A | |
Recruiting |
NCT06041945 -
Artificial Intelligence to Implement Cost-saving Strategies for Colonoscopy Screening Based on in Vivo Prediction of Polyp Histology
|
N/A | |
Not yet recruiting |
NCT02688699 -
Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract
|
Phase 4 | |
Not yet recruiting |
NCT03175146 -
A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely
|
N/A | |
Completed |
NCT02529007 -
Endo-cuff Assisted Vs. Standard Colonoscopy for Polyp Detection in Bowel Cancer Screening
|
N/A | |
Not yet recruiting |
NCT01929499 -
Efficacy of Adjuvant Cytokine-induced Killer Cells in Colon Cancer
|
Phase 2 | |
Completed |
NCT01681472 -
PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT01438645 -
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
|
N/A | |
Completed |
NCT00535652 -
Concentration of Ertapenem in Colorectal Tissue
|
Phase 4 | |
Terminated |
NCT00267787 -
Molecular Genetic and Pathological Studies of Anal Tumors
|
||
Completed |
NCT05498051 -
Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Submucosal Bevacizumab-800CW.
|
N/A | |
Recruiting |
NCT05068180 -
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
|
Phase 4 | |
Recruiting |
NCT03314896 -
Laparoscopic Surgery for T4 Tumor of the Colon Cancer (LST4C Trial)
|
N/A | |
Not yet recruiting |
NCT02777437 -
Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT02852915 -
Laparoscopic Surgery for T4 Tumor of the Colon Cancer
|
Phase 3 | |
Completed |
NCT00997802 -
Japanese National Computed Tomographic (CT) Colonography Trial
|
N/A | |
Completed |
NCT01056913 -
NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery
|
Phase 4 | |
Completed |
NCT00470782 -
Aerobic Capacity and Body Composition in Colon Cancer Patients
|
N/A | |
Completed |
NCT00537901 -
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
|
N/A | |
Completed |
NCT00275210 -
MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer
|
Phase 3 |